This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Becton Dickinson (BDX) Gets a Hold from Piper Sandler

Tipranks - Tipranks - Thu May 28, 6:52AM CDT

Piper Sandler analyst Jason Bednar maintained a Hold rating on Becton Dickinson today and set a price target of $161.00.

Memorial Day Sale – Claim 70% Off TipRanks

According to TipRanks, Bednar is an analyst with an average return of -5.5% and a 38.89% success rate. Bednar covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, ICU Medical, and Align Tech.

Currently, the analyst consensus on Becton Dickinson is a Moderate Buy with an average price target of $182.40.

See the top stocks recommended by analysts >>

Based on Becton Dickinson’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.71 billion and a GAAP net loss of $311 million. In comparison, last year the company earned a revenue of $5.27 billion and had a net profit of $308 million

Read More on BDX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).